PLRX
Price
$1.40
Change
+$0.03 (+2.21%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
83.49M
31 days until earnings call
SVRA
Price
$2.30
Change
-$0.07 (-2.95%)
Updated
Jul 10 closing price
Capitalization
409.62M
27 days until earnings call
Interact to see
Advertisement

PLRX vs SVRA

Header iconPLRX vs SVRA Comparison
Open Charts PLRX vs SVRABanner chart's image
Pliant Therapeutics
Price$1.40
Change+$0.03 (+2.21%)
Volume$15.24K
Capitalization83.49M
Savara
Price$2.30
Change-$0.07 (-2.95%)
Volume$470.65K
Capitalization409.62M
PLRX vs SVRA Comparison Chart in %
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. SVRA commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a StrongBuy and SVRA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (PLRX: $1.40 vs. SVRA: $2.30)
Brand notoriety: PLRX and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 66% vs. SVRA: 25%
Market capitalization -- PLRX: $83.49M vs. SVRA: $409.62M
PLRX [@Biotechnology] is valued at $83.49M. SVRA’s [@Biotechnology] market capitalization is $409.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, PLRX is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 6 TA indicator(s) are bullish while SVRA’s TA Score has 5 bullish TA indicator(s).

  • PLRX’s TA Score: 6 bullish, 3 bearish.
  • SVRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than SVRA.

Price Growth

PLRX (@Biotechnology) experienced а +11.11% price change this week, while SVRA (@Biotechnology) price change was +5.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

PLRX is expected to report earnings on Nov 11, 2025.

SVRA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SVRA($410M) has a higher market cap than PLRX($83.5M). SVRA YTD gains are higher at: -25.081 vs. PLRX (-89.370). SVRA has higher annual earnings (EBITDA): -108.24M vs. PLRX (-214.08M). PLRX has more cash in the bank: 306M vs. SVRA (172M). SVRA has less debt than PLRX: SVRA (29.6M) vs PLRX (60.2M). PLRX (0) and SVRA (0) have equivalent revenues.
PLRXSVRAPLRX / SVRA
Capitalization83.5M410M20%
EBITDA-214.08M-108.24M198%
Gain YTD-89.370-25.081356%
P/E RatioN/AN/A-
Revenue00-
Total Cash306M172M178%
Total Debt60.2M29.6M203%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXSVRA
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 24 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AANNF3.66N/A
N/A
Aroundtown SA
BACHF0.61N/A
N/A
Bank of China, Ltd.
IRCKF0.55N/A
N/A
Inter-Rock Minerals, Inc.
PSDMF0.65N/A
N/A
Gaming Realms PLC
TELDF2.67N/A
N/A
Telefonica Deutschland Holding AG

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+2.94%
LXRX - PLRX
41%
Loosely correlated
+5.61%
ITRM - PLRX
41%
Loosely correlated
+15.76%
OCUL - PLRX
41%
Loosely correlated
+2.97%
SRRK - PLRX
41%
Loosely correlated
+3.04%
FHTX - PLRX
40%
Loosely correlated
-2.00%
More